This brand name is authorized in Nigeria.
The drug TREXIP-TZ contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
|
|
Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination. |
|
2
|
UNII
033KF7V46H - TINIDAZOLE
|
|
Tinidazole is active against both protozoa and obligate anaerobic bacteria. The activity against protozoa involves Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia. The mode of action of tinidazole against anaerobic bacteria and protozoa involves penetration of the drug into the cell of the micro-organism and subsequent damage of DNA strands or inhibition of their synthesis. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-6072 | Tablet | Trexip-TZ Tablets TAB 500 mg; 600 mg | TREXIP-TZ TABLETS A4-6072 TREXIP-TZ TABLETS CIPROFLOXACIN BP 500MG & TINIDAZOLE BP 600MG, CROSCARMELLOSE SODIUM,MAIZE STARCH,GELATIN,PURIFIED WATER,MAGNESIUM STEARATE,PURIFIED TALC,SOLUBLE STARCH,FC TITANIUM DIOXIDE,ISOPROPYL ALCOHOL Tablet POM 1 GREENLIFE PHARMACEUTICAL LIMITED, ASSOCIATION AVENUE, ILUPEJU LAGOS LAGOS Nigeria M/S MCW HEALTHCARE(P) LTD, 286, 287-A, 287-B, SECTOR-E, INDUSTRIAL AREA, SANWER ROAD, INDORE (M.P), INDIA, India 26/01/2023 25/01/2028 | 26/01/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01RA11 | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01R Combinations of antibacterials → J01RA Combinations of antibacterials | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-6072 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.